ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652561 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652561; 2) Community: the network communities that were significantly associated with the response to NSC 652561; 3) Molecule: the relationships between components within communities and NSC 652561; 4) MDR: the compounds that were significantly associated with the NSC 652561.

NSC Compound Enrichment Correlation
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.00803384002766641 0.42760573
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.00803384002766641 -0.1801334
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.00803384002766641 0.35627651
NSC 359239 Antibiotic X-14766A 0.00803384002766641 0.07157525
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.00803384002766641 0.2567355
NSC 603071 Aminocamptothecin 0.00803384002766641 0.19347465
NSC 642324 Null 0.00803384002766641 0.23695823
NSC 683556 Camptothecin Derivative 0.00803384002766641 0.37259744
NSC 694075 Null 0.00803384002766641 0.21399541
NSC 700363 Liposomal Annamycin 0.00803384002766641 0.27126673
Total:65  Current:15    [First] [Prev] [Next] [Last]